Home > Insider Trading > Filing (0001764013-23-000010)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1764013	Immunovant Inc.	IMVT	Biological Products, (No Disgnostic Substances) (2836)	832771572

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1796290	G. Julia Butchko	C/O Immunovant, Inc. 320 W 37Th Street, 6Th Floor New York NY 10018	Chief Dev. & Tech. Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-01-11	19	$15.16	391,890	No	4	S	Direct
Common Stock	Disposition	2023-01-11	60,471	$16.79	331,419	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 3,407 of these RSUs vested on January 1, 2023. On August 3, 2021, the holder was granted 285,306 RSUs, as previously reported on a Form 4 filed on August 4, 2021, of which the remaining 142,653 of these RSUs vested on January 1, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligations due in connection with the vesting and settlement of these tranches of the RSUs and do not represent a discretionary sale by the holder.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.68 - $16.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.